122 related articles for article (PubMed ID: 29134720)
1. Investigation of sarin(Se) reactivity against human plasma proteins using liquid chromatography-tandem mass spectrometry.
Saeidian H; Hosseini SE; Amoozadeh A; Naseri MT; Babri M
J Mass Spectrom; 2018 Feb; 53(2):138-145. PubMed ID: 29134720
[TBL] [Abstract][Full Text] [Related]
2. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
Tsuge K; Seto Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
[TBL] [Abstract][Full Text] [Related]
3. Online coupling of immunoextraction, digestion, and microliquid chromatography-tandem mass spectrometry for the analysis of sarin and soman-butyrylcholinesterase adducts in human plasma.
Bonichon M; Valbi V; Combès A; Desoubries C; Bossée A; Pichon V
Anal Bioanal Chem; 2018 Jan; 410(3):1039-1051. PubMed ID: 28971225
[TBL] [Abstract][Full Text] [Related]
4. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
[TBL] [Abstract][Full Text] [Related]
5. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
6. Modifications to the organophosphorus nerve agent-protein adduct refluoridation method for retrospective analysis of nerve agent exposures.
Holland KE; Solano MI; Johnson RC; Maggio VL; Barr JR
J Anal Toxicol; 2008; 32(1):116-24. PubMed ID: 18269803
[TBL] [Abstract][Full Text] [Related]
7. Development of an automated on-line pepsin digestion-liquid chromatography-tandem mass spectrometry configuration for the rapid analysis of protein adducts of chemical warfare agents.
Carol-Visser J; van der Schans M; Fidder A; Hulst AG; van Baar BL; Irth H; Noort D
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):91-7. PubMed ID: 18573700
[TBL] [Abstract][Full Text] [Related]
8. Quantification of nerve agent adducts with albumin in rat plasma using liquid chromatography-isotope dilution tandem mass spectrometry.
Bao Y; Liu Q; Chen J; Lin Y; Wu B; Xie J
J Chromatogr A; 2012 Mar; 1229():164-71. PubMed ID: 22305360
[TBL] [Abstract][Full Text] [Related]
9. Verification of exposure to cholinesterase inhibitors: generic detection of OPCW Schedule 1 nerve agent adducts to human butyrylcholinesterase.
van der Schans MJ; Fidder A; van Oeveren D; Hulst AG; Noort D
J Anal Toxicol; 2008; 32(1):125-30. PubMed ID: 18269804
[TBL] [Abstract][Full Text] [Related]
10. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
[TBL] [Abstract][Full Text] [Related]
11. Small-scale purification of butyrylcholinesterase from human plasma and implementation of a μLC-UV/ESI MS/MS method to detect its organophosphorus adducts.
John H; Breyer F; Schmidt C; Mizaikoff B; Worek F; Thiermann H
Drug Test Anal; 2015 Oct; 7(10):947-56. PubMed ID: 25828536
[TBL] [Abstract][Full Text] [Related]
12. Formation of pyrophosphate-like adducts from nerve agents sarin, soman and cyclosarin in phosphate buffer: implications for analytical and toxicological investigations.
Gäb J; John H; Blum MM
Toxicol Lett; 2011 Jan; 200(1-2):34-40. PubMed ID: 20979985
[TBL] [Abstract][Full Text] [Related]
13. Stable adducts of nerve agents sarin, soman and cyclosarin with TRIS, TES and related buffer compounds--characterization by LC-ESI-MS/MS and NMR and implications for analytical chemistry.
Gäb J; John H; Melzer M; Blum MM
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1382-90. PubMed ID: 20172768
[TBL] [Abstract][Full Text] [Related]
14. Quantification of sarin and cyclosarin metabolites isopropyl methylphosphonic acid and cyclohexyl methylphosphonic acid in minipig plasma using isotope-dilution and liquid chromatography- time-of-flight mass spectrometry.
Evans RA; Jakubowski EM; Muse WT; Matson K; Hulet SW; Mioduszewski RJ; Thomson SA; Totura AL; Renner JA; Crouse CL
J Anal Toxicol; 2008; 32(1):78-85. PubMed ID: 18269798
[TBL] [Abstract][Full Text] [Related]
15. A gas chromatographic-mass spectrometric approach to examining stereoselective interaction of human plasma proteins with soman.
Yeung DT; Smith JR; Sweeney RE; Lenz DE; Cerasoli DM
J Anal Toxicol; 2008; 32(1):86-91. PubMed ID: 18269799
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography electrospray tandem mass spectrometric and desorption electrospray ionization tandem mass spectrometric analysis of chemical warfare agents in office media typically collected during a forensic investigation.
D'Agostino PA; Hancock JR; Chenier CL; Lepage CR
J Chromatogr A; 2006 Mar; 1110(1-2):86-94. PubMed ID: 16480731
[TBL] [Abstract][Full Text] [Related]
17. A Novel, Modified Human Butyrylcholinesterase Catalytically Degrades the Chemical Warfare Nerve Agent, Sarin.
McGarry KG; Lalisse RF; Moyer RA; Johnson KM; Tallan AM; Winters TP; Taris JE; McElroy CA; Lemmon EE; Shafaat HS; Fan Y; Deal A; Marguet SC; Harvilchuck JA; Hadad CM; Wood DW
Toxicol Sci; 2020 Mar; 174(1):133-146. PubMed ID: 31879758
[TBL] [Abstract][Full Text] [Related]
18. Verification of exposure to chemical warfare agents through analysis of persistent biomarkers in plants.
de Bruin-Hoegée M; Lamriti L; Langenberg JP; Olivier RCM; Chau LF; van der Schans MJ; Noort D; van Asten AC
Anal Methods; 2023 Jan; 15(2):142-153. PubMed ID: 36524843
[TBL] [Abstract][Full Text] [Related]
19. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
20. Characterization of isomeric VX nerve agent adducts on albumin in human plasma using liquid chromatography-tandem mass spectrometry.
Saeidian H; Mirkhani V; Mousavi Faraz S; Taghi Naseri M; Babri M
Eur J Mass Spectrom (Chichester); 2015; 21(6):783-9. PubMed ID: 26764308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
